Co-Authors
This is a "connection" page, showing publications co-authored by KAREN H LU and ZHEN LU.
Connection Strength
0.437
-
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol. 2008 Aug; 110(2):196-201.
Score: 0.080
-
Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol. 2024 Apr 01; 42(10):1102-1109.
Score: 0.059
-
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer. Br J Cancer. 2024 Mar; 130(5):861-868.
Score: 0.059
-
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. Clin Cancer Res. 2022 11 01; 28(21):4669-4676.
Score: 0.054
-
Biomarkers and Strategies for Early Detection of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2504-2512.
Score: 0.047
-
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer. Cancer. 2020 02 15; 126(4):725-736.
Score: 0.044
-
Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5912-5922.
Score: 0.037
-
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 2008 Apr 01; 112(7):1489-502.
Score: 0.020
-
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment. Gynecol Oncol. 2007 Sep; 106(3):490-7.
Score: 0.019
-
Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007; 174:91-100.
Score: 0.018